This work is licensed under the Creative Commons Attribution 4.0 International License.
Krawiec P, Pac-Kożuchowska E. Rola hepcydyny w metabolizmie żelaza w przebiegu nieswoistych zapaleń jelit. Postępy Hig Med. Dośw. 2014;68:936-943.KrawiecPPac-KożuchowskaERola hepcydyny w metabolizmie żelaza w przebiegu nieswoistych zapaleń jelit20146893694310.5604/17322693.1111365Search in Google Scholar
Ganz T. Iron homeostasis: Fitting the puzzle pieces together. Cell Metab. 2008;7(4):288-290. doi: 10.1016/j. cmet.2008.03.008.GanzTIron homeostasis: Fitting the puzzle pieces together20087428829010.1016/j.cmet.2008.03.008Open DOISearch in Google Scholar
Jonker FAM, Te Poel E, Bates I, Boele van Hensbroek M. Anaemia, iron deficiency and susceptibility to infection in children in sub-Saharan Africa, guideline dilemmas. Br J Haematol. 2017;177(6):878-883. doi: 10.111 1/bjh.14593.JonkerFAMTe PoelEBatesIBoele van HensbroekMAnaemia, iron deficiency and susceptibility to infection in children in sub-Saharan Africa, guideline dilemmas2017177687888310.1111/bjh.14593Open DOISearch in Google Scholar
de Pontual L. [Iron and susceptibility to infections]. [Article in French], Arch Pediatr. 2017;24(5S):5S14-5S17. doi: 10.1016/S0929-693X(17)24004-4.de PontualL[Iron and susceptibility to infections]. [Article in French]2017245S5S145S1710.1016/S0929-693X(17)24004-4Open DOISearch in Google Scholar
Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet 2006;367(9505):133-143. doi: 10.1016/S0140-6736(06)67962-2.SazawalSBlackRERamsanMChwayaHMStoltzfusRJDuttaADhingraUKaboleIDebSOthmanMKKaboleFMEffects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial2006367950513314310.1016/S0140-6736(06)67962-2Open DOISearch in Google Scholar
Wegmüller R, Bah A, Kendall L, Goheen MM, Mulwa S, Cerami C, Moretti D, Prentice AM. Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: A double-blind randomised controlled trial. BMC Pediatr. 2016;16(1):149. doi: 10.1186/sl2887-016-0689-4.WegmüllerRBahAKendallLGoheenMMMulwaSCeramiCMorettiDPrenticeAMEfficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: A double-blind randomised controlled trial201616114910.1186/sl2887-016-0689-4Open DOISearch in Google Scholar
Agoro R, Benmerzoug S, Rose S, Bouyer M, Gozzelino R, Garcia I, Ryffel B, Quesniaux VFJ, Mura C. An Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates with Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin Infection. J Infect Dis. 2017;216(7):907-918. doi: 10.1093/infdis/ jix366.AgoroRBenmerzougSRoseSBouyerMGozzelinoRGarciaIRyffelBQuesniauxVFJMuraCAn Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates with Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin Infection2017216790791810.1093/infdis/jix36628973651Open DOISearch in Google Scholar
Michels KR, Zhang Z, Bettina AM, Cagnina RE, Stefanova D, Burdick MD, Vaulont S, Nemeth E, Ganz T, Mehrad B. Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia. JCI Insight. 2017;2(6):e92002. doi: 10.1172/jci.insight.92002.MichelsKRZhangZBettinaAMCagninaREStefanovaDBurdickMDVaulontSNemethEGanzTMehradBHepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia201726e9200210.1172/jci.insight.92002535849228352667Open DOISearch in Google Scholar
Budnevsky AV, Esaulenko IE, Ovsyannikov ES, Labzhaniya NB, Voronina EV, Chernov AV. [Anemic syndrome in patients with community-acquired pneumonia]. [Article in Russian]. Klin Med (Mosk). 2016;94(1):56-60.BudnevskyAVEsaulenkoIEOvsyannikovESLabzhaniyaNBVoroninaEVChernovAV[Anemic syndrome in patients with community-acquired pneumonia]. [Article in Russian]2016941566010.18821/0023-2149-2016-94-1-56-60Search in Google Scholar
Schoorl M, Snijders D, Schoorl M, Boersma WG, Bartels PC. Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia. Scand J Clin Lab Invest. 2013;73(1):54-60. doi: 10.3109/00365513.2012.735694.SchoorlMSnijdersDSchoorlMBoersmaWGBartelsPCTransient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia2013731546010.3109/00365513.2012.73569423098343Open DOISearch in Google Scholar
Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016;23(3):189-97. doi: 10.1097/MOH.0000000000000236.WangCYBabittJLHepcidin regulation in the anemia of inflammation20162331899710.1097/MOH.0000000000000236499315926886082Open DOISearch in Google Scholar
Tacke F, Nuraldeen R, Koch A, Strathmann K, Hutschenreuter G, Trautwein C, Strnad P. Iron Parameters Determine the Prognosis of Critically Ill Patients. Crit Care Med. 2016;44(6): 1049-1058. doi: 10.1097/ CCM.0000000000001607.TackeFNuraldeenRKochAStrathmannKHutschenreuterGTrautweinCStrnadPIron Parameters Determine the Prognosis of Critically Ill Patients20164461049105810.1097/CCM.000000000000160726934143Open DOISearch in Google Scholar
Houamel D, Ducrot N, Lefebvre T, Daher R, Moulouel B, Sari MA, Letteron P, Lyoumi S, Millot S, Tourret J, Bouvet O, Vaulont S, Vandewalle A, Denamur E, Puy H, Beaumont C, Gouya L, Karim Z. Hepcidin as a major component of renal antibacterial defenses against uropathogenic Escherichia coli. J Am Soc Nephrol. 2016;27(3):835-846. doi: 10.1681/ ASN.2014101035.HouamelDDucrotNLefebvreTDaherRMoulouelBSariMALetteronPLyoumiSMillotSTourretJBouvetOVaulontSVandewalleADenamurEPuyHBeaumontCGouyaLKarimZHepcidin as a major component of renal antibacterial defenses against uropathogenic Escherichia coli201627383584610.1681/ASN.2014101035476918726293821Open DOISearch in Google Scholar
Mahajan G, Sharma S, Chandra J, Nangia A. Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia. Blood Res. 2017;52(3): 212-217. doi: 10.5045/br.2017.52.3.212.MahajanGSharmaSChandraJNangiaAHepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia201752321221710.5045/br.2017.52.3.212564151429043237Open DOISearch in Google Scholar
Weiss G. Anemia of chronic disorders: New diagnostic tools and new treatment strategies. Semin Hematol. 2015;52(4):313--20. doi: 10.1053/j.seminhematol.2015.07.004.WeissGAnemia of chronic disorders: New diagnostic tools and new treatment strategies20155243132010.1053/j.seminhematol.2015.07.00426404443Open DOISearch in Google Scholar
Stefanova KI, Delcheva GT, Maneva AI, Batalov AZ, Geneva-Popova MG, Karalilova RV, Simitchiev KK. Pathobiochemical mechanisms relating iron homeostasis to parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis. Folia Med (Plovdiv). 2016;58(4):257-263. doi: 10.1515/folmed-2016-0040.StefanovaKIDelchevaGTManevaAIBatalovAZGeneva-PopovaMGKaralilovaRVSimitchievKKPathobiochemical mechanisms relating iron homeostasis to parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis201658425726310.1515/folmed-2016-004028068286Open DOISearch in Google Scholar
Krawiec P, Mroczkowska-Juchkiewicz A, Pac-Kożuchowska E. Serum hepcidin in children with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(12):2165-2171. doi: 10.1097/MIB.0000000000001245.KrawiecPMroczkowska-JuchkiewiczAPac-KożuchowskaESerum hepcidin in children with inflammatory bowel disease201723122165217110.1097/MIB.000000000000124528945637Open DOISearch in Google Scholar
Huang YH, Kuo HC. Anemia in Kawasaki disease: Hepcidin as a potential biomarker. Dallinger R, ed. Int J Mol Sci. 2017; 18(4):820. doi: 10.3390/ijms18040820.HuangYHKuoHCAnemia in Kawasaki disease: Hepcidin as a potential biomarkerDallingerR201718482010.3390/ijms18040820541240428417923Open DOISearch in Google Scholar
Hutchinson C. A review of iron studies in overweight and obese children and adolescents: a double burden in the young? Eur J Nutr. 2016;55(7):2179-97. doi: 10.1007/ s00394-016-1155-7.HutchinsonCA review of iron studies in overweight and obese children and adolescents: a double burden in the young?201655721799710.1007/s00394-016-1155-726883916Open DOISearch in Google Scholar
Moreno-Navarrete JM, Moreno M, Puig J, Blasco G, Ortega F, Xifra G, Ricart W, Fernández-Real AM. Hepatic iron content is independently associated with serum hepcidin levels in subjects with obesity. Clin Nutr. 2017;36(5):1434-1439. doi: 10.1016/j.clnu.2016.09.022.Moreno-NavarreteJMMorenoMPuigJBlascoGOrtegaFXifraGRicartWFernández-RealAMHepatic iron content is independently associated with serum hepcidin levels in subjects with obesity20173651434143910.1016/j.clnu.2016.09.02227745814Open DOISearch in Google Scholar
Andrews M, Soto N, Arredondo-Olguin M. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Nutrition. 2015; 31 (1):51-57. doi: 10.1016/j.nut.2014.04.019.AndrewsMSotoNArredondo-OlguinMAssociation between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity2015311515710.1016/j.nut.2014.04.01925441587Open DOISearch in Google Scholar
Aregbesola A, Voutilainen S, Virtanen JK, Aregbesola A, Tuomainen TP. Serum hepcidin concentrations and type 2 diabetes. World J Diabetes. 2015;6(7):978-982. doi: 10.4239/wjd.v6.i7.978.AregbesolaAVoutilainenSVirtanenJKAregbesolaATuomainenTPSerum hepcidin concentrations and type 2 diabetes20156797898210.4239/wjd.v6.i7.978449953126185605Open DOISearch in Google Scholar
Makis A, Hatzimichael E, Papassotiriou I, Voskaridou E. 2017 Clinical trials update in new treatments of β-thalassemia. Am J Hematol. 2016;91(11): 1135-1145. doi: 10.1002/ajh.24530.MakisAHatzimichaelEPapassotiriouIVoskaridouE.2017Clinical trials update in new treatments of β-thalassemia201691111135114510.1002/ajh.2453027502996Open DOISearch in Google Scholar
Kawabata H. Progress in iron metabolism research. Rinsho Ketsueki The Japanese Journal of Clinical Hematology. 2017;58(10):1864-1871. doi: 10.11406/rinketsu.58.1864.KawabataHProgress in iron metabolism research201758101864187110.11406/rinketsu.58.186428978826Open DOISearch in Google Scholar
Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G. Low serum hepcidin in patients with autoimmune liver diseases. PLoS One. 2015;10(8):e0135486. doi: 10.1371/journal.pone.0135486.LyberopoulouAChachamiGGatselisNKKyratzopoulouESaitisAGabetaSEliadesPParaskevaEZachouKKoukoulisGKMamalakiADalekosGNSimosGLow serum hepcidin in patients with autoimmune liver diseases2015108e013548610.1371/journal.pone.0135486453588426270641Open DOISearch in Google Scholar
Cakir M, Erduran E, Turkmen ES, Aliyazicioglu Y, Reis GP, Cobanoglu U, Demir S. Hepcidin levels in children with chronic liver disease. Saudi J Gastroenterol. 2015;21(5):300-305. doi: 10.4103/1319-3767.166205.CakirMErduranETurkmenESAliyaziciogluYReisGPCobanogluUDemirSHepcidin levels in children with chronic liver disease201521530030510.4103/1319-3767.166205463225526458857Open DOISearch in Google Scholar
Cylwik B, Chrostek L, Szmitkowski M. Wpływ alkoholu na mechanizmy regulacyjne metabolizmu żelaza. [The effect of alcohol on the regulation of iron metabolism]. [Article in Polish]. Pol Merkur Lekarski. 2008;25(147):273-275.CylwikBChrostekLSzmitkowskiMWpływ alkoholu na mechanizmy regulacyjne metabolizmu żelaza. [The effect of alcohol on the regulation of iron metabolism]. [Article in Polish]200825147273275Search in Google Scholar
Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol. 2009;122(2-3):78-86. doi: 10.1159/000243791.NemethEGanzTThe role of hepcidin in iron metabolism20091222-3788610.1159/000243791285527419907144Open DOISearch in Google Scholar
Ueda N, Takasawa K. Role of Hepcidin-25 in chronic kidney disease: Anemia and beyond. Curr Med Chem. 2017;24(14):1417-1452. doi: 10.2174/092986732466617 0316120538.UedaNTakasawaKRole of Hepcidin-25 in chronic kidney disease: Anemia and beyond201724141417145210.2174/092986732466617 0316120538Open DOISearch in Google Scholar
Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS One. 2014;9(6):e99781. doi: 10.1371/ journal.pone.0099781.MercadalLMetzgerMHaymannJPThervetEBoffaJJFlamantMVrtovsnikFHouillierPFroissartMStengelBNephroTest Study Group. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease201496e9978110.1371/journal.pone.0099781407618924978810Open DOISearch in Google Scholar
van Eijk LT, John AS, Schwoebel F, Summo L, Vauléon S, Zöllner S, Laarakkers CM, Kox M, van der Hoeven JG, Swinkels DW, Riecke K, Pickkers P. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. Blood. 2014;124(17):2643-2646. doi: 10.1182/blood-2014-03-559484.van EijkLTJohnASSchwoebelFSummoLVauléonSZöllnerSLaarakkersCMKoxMvan der HoevenJGSwinkelsDWRieckeKPickkersPEffect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans2014124172643264610.1182/blood-2014-03-559484420827925163699Open DOISearch in Google Scholar
Reichert CO, da Cunha J, Levy D, Maselli LMF, Bydlowski SP, Spada C. Hepcidin: Homeostasis and diseases related to iron metabolism. Acta Haematol. 2017;137(4):220-236. doi: 10.1159/000471838.ReichertCOda CunhaJLevyDMaselliLMFBydlowskiSPSpadaCHepcidin: Homeostasis and diseases related to iron metabolism2017137422023610.1159/00047183828514781Open DOISearch in Google Scholar
Liu J, Sun B, Yin H, Liu S. Hepcidin: A promising therapeutic target for iron disorders: A systematic review. Medicine (Baltimore). 2016;95(14):e3150. doi: 10.1097/ MD.0000000000003150.LiuJSunBYinHLiuSHepcidin: A promising therapeutic target for iron disorders: A systematic review20169514e315010.1097/MD.0000000000003150499875527057839Open DOISearch in Google Scholar